Financial Snapshot

Revenue
$2.436M
TTM
Gross Margin
-31.12%
TTM
Net Earnings
$4.513M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
134.04%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$85.13M
Q3 2024
Cash
Q3 2024
P/E
2.944
Nov 29, 2024 EST
Free Cash Flow
-$8.468M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2008 2007 2006
Revenue $8.272M $11.45M $9.889M $17.12M $7.440M $3.830M $2.930M $2.480M $2.910M $1.500M $960.0K $0.00 $0.00 $0.00
YoY Change -27.74% 15.76% -42.23% 130.11% 94.26% 30.72% 18.15% -14.78% 94.0% 56.25%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2008 2007 2006
Revenue $8.272M $11.45M $9.889M $17.12M $7.440M $3.830M $2.930M $2.480M $2.910M $1.500M $960.0K $0.00 $0.00 $0.00
Cost Of Revenue $5.674M $5.997M $5.143M $11.42M $2.570M $450.0K $20.00K $190.0K $440.0K $940.0K
Gross Profit $2.598M $5.451M $4.746M $5.710M $4.870M $3.380M $2.470M $2.720M $1.060M $10.00K
Gross Profit Margin 31.41% 47.62% 47.99% 33.35% 65.46% 88.25% 99.6% 93.47% 70.67% 1.04%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2008 2007 2006
Selling, General & Admin $9.862M $8.208M $8.812M $7.490M $4.380M $3.470M $2.540M $3.450M $2.860M $2.490M $2.100M $30.00K $30.00K $10.00K
YoY Change 20.15% -6.86% 17.65% 71.0% 26.22% 36.61% -26.38% 20.63% 14.86% 18.57% 0.0% 200.0%
% of Gross Profit 379.55% 150.57% 185.67% 131.17% 89.94% 102.66% 139.68% 105.15% 234.91% 21000.0%
Research & Development $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $19.38K $14.64K $7.350K $10.00K $10.00K $0.00 $0.00 $0.00 $0.00
YoY Change 32.37% 99.14% -26.5% 0.0%
% of Gross Profit 0.75% 0.27% 0.15% 0.18% 0.21% 0.0% 0.0% 0.0% 0.0%
Operating Expenses $9.862M $9.876M $8.812M $7.480M $4.370M $3.470M $2.530M $3.440M $2.860M $2.480M $2.100M $30.00K $30.00K $10.00K
YoY Change -0.14% 12.07% 17.81% 71.17% 25.94% 37.15% -26.45% 20.28% 15.32% 18.1% 0.0% 200.0%
Operating Profit -$7.263M -$4.424M -$4.066M -$1.770M $500.0K -$90.00K -$970.0K -$140.0K -$1.420M -$2.090M
YoY Change 64.17% 8.82% 129.71% -454.0% -655.56% 592.86% -90.14% -32.06%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2008 2007 2006
Interest Expense $1.198M $336.2K -$23.59K -$30.00K -$300.0K -$60.00K -$160.0K -$150.0K -$120.0K $0.00 -$10.00K
YoY Change 256.43% -1525.21% -21.37% -90.0% 400.0% -62.5% 6.67% 25.0% -100.0%
% of Operating Profit -60.0%
Other Income/Expense, Net -$6.457M $514.4K -$23.59K $0.00 $70.00K $160.0K $70.00K
YoY Change -1355.21% -2280.7% -100.0% -56.25% 128.57%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2008 2007 2006
Pretax Income -$13.72M -$3.910M -$5.316M -$2.540M -$280.0K $10.00K $290.0K -$1.170M -$260.0K -$2.010M -$2.090M -$30.00K -$30.00K -$10.00K
YoY Change 250.92% -26.45% 109.29% 807.14% -2900.0% -96.55% -124.79% 350.0% -87.06% -3.83% 0.0% 200.0%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$17.84M -$3.472M -$5.316M -$2.540M -$280.0K $10.00K $290.0K -$2.760M -$1.120M -$2.010M -$2.090M -$30.00K -$30.00K -$10.00K
YoY Change 413.91% -34.68% 109.29% 807.14% -2900.0% -96.55% -110.51% 146.43% -44.28% -3.83% 0.0% 200.0%
Net Earnings / Revenue -215.7% -30.33% -53.75% -14.84% -3.76% 0.26% 9.9% -111.29% -38.49% -134.0% -217.71%
Basic Earnings Per Share -$23.35 -$0.41 -$0.65
Diluted Earnings Per Share -$7.49 -$0.41 -$653.3K -$329.4K -$47.22K $1.715K $51.06K -$524.7K -$214.6K -$404.4K -$889.4K -$1.500M -$1.500M -$1.000M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2008 2007 2006
Cash & Short-Term Investments $151.9K $1.134M $3.123M $5.920M $2.870M $870.0K $180.0K $10.00K $80.00K $710.0K $80.00K $0.00 $0.00 $10.00K
YoY Change -86.6% -63.7% -47.25% 106.27% 229.89% 383.33% 1700.0% -87.5% -88.73% 787.5% -100.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $107.8K $110.9K $216.4K $150.0K $80.00K $80.00K $100.0K $20.00K $1.600M $120.0K $0.00
YoY Change -2.86% -48.74% 44.27% 87.5% 0.0% -20.0% 400.0% -98.75% 1233.33%
Inventory $970.00 $119.6K $56.28K $1.260M $60.00K $80.00K $50.00K $40.00K
Prepaid Expenses
Receivables $821.8K $729.0K $979.0K $810.0K $790.0K $430.0K $320.0K $300.0K $350.0K $350.0K $110.0K
Other Receivables $1.671M $0.00 $0.00 $1.080M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $160.0K
Total Short-Term Assets $2.753M $2.093M $4.374M $9.220M $3.800M $1.470M $610.0K $340.0K $2.030M $1.220M $400.0K $0.00 $0.00 $10.00K
YoY Change 31.53% -52.15% -52.56% 142.63% 158.5% 140.98% 79.41% -83.25% 66.39% 205.0% -100.0%
Property, Plant & Equipment $806.6K $1.117M $1.332M $550.0K $930.0K $20.00K $0.00 $10.00K
YoY Change -27.79% -16.13% 142.14% -40.86% 4550.0% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.53K $49.03K $60.14K $20.00K $110.0K $20.00K $10.00K
YoY Change -78.52% -18.47% 200.7% -81.82% 450.0% 100.0%
Total Long-Term Assets $9.780M $1.617M $1.392M $570.0K $1.770M $760.0K $10.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 504.85% 16.16% 144.2% -67.8% 132.89% 7500.0%
Total Assets $12.53M $3.710M $5.766M $9.790M $5.570M $2.230M $620.0K $340.0K $2.030M $1.220M $400.0K $0.00 $0.00 $10.00K
YoY Change
Accounts Payable $2.082M $729.2K $477.0K $260.0K $330.0K $400.0K $110.0K $240.0K $220.0K $290.0K $160.0K $10.00K $10.00K $0.00
YoY Change 185.54% 52.85% 83.47% -21.21% -17.5% 263.64% -54.17% 9.09% -24.14% 81.25% 0.0%
Accrued Expenses $540.7K $486.9K $449.0K $350.0K $190.0K $140.0K $160.0K $470.0K $250.0K $180.0K $40.00K
YoY Change 11.05% 8.44% 28.29% 84.21% 35.71% -12.5% -65.96% 88.0% 38.89% 350.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $320.0K $260.0K $770.0K $400.0K $0.00 $70.00K $20.00K $0.00 $0.00
YoY Change -100.0% 23.08% -66.23% 92.5% -100.0%
Long-Term Debt Due $6.530M $166.7K $0.00 $230.0K
YoY Change 3817.92% -100.0%
Total Short-Term Liabilities $11.56M $2.147M $926.0K $840.0K $520.0K $860.0K $530.0K $1.470M $1.760M $550.0K $270.0K $50.00K $20.00K $0.00
YoY Change 438.31% 131.83% 10.24% 61.54% -39.53% 62.26% -63.95% -16.48% 220.0% 103.7% 150.0%
Long-Term Debt $25.00K $333.3K $0.00 $0.00 $230.0K $520.0K $400.0K $10.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -92.5% -100.0% -55.77% 30.0% 3900.0%
Other Long-Term Liabilities $409.2K $887.0K $1.070M $270.0K $690.0K
YoY Change -53.87% -17.1% 296.29% -60.87%
Total Long-Term Liabilities $434.2K $1.220M $1.070M $270.0K $920.0K $520.0K $400.0K $10.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -64.42% 14.06% 296.29% -70.65% 76.92% 30.0% 3900.0%
Total Liabilities $11.99M $2.947M $1.996M $1.110M $1.430M $1.380M $930.0K $1.490M $1.760M $550.0K $270.0K $50.00K $20.00K $0.00
YoY Change 306.89% 47.64% 79.82% -22.38% 3.62% 48.39% -37.58% -15.34% 220.0% 103.7% 150.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2008 2007 2006
Basic Shares Outstanding 764.1K shares 8.473M shares 8.137M shares
Diluted Shares Outstanding 2.381M shares 566.6K shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $13.283 Million

About Scienture Holdings, Inc.

TRxADE HEALTH, Inc. is a health services information technology company, which focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. The company is headquartered in Lutz, Florida and currently employs 8 full-time employees. The company went IPO on 2020-02-18. The firm is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patient’s home and patient engagement in the United States. The Company’s segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientia’s intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.

Industry: Pharmaceutical Preparations Peers: AMAZON COM INC Fovea Jewelry Holdings Ltd. Legacy IMBDS, Inc. Starco Brands, Inc. KIDPIK CORP. SCIENTIFIC ENERGY, INC SHARING SERVICES GLOBAL Corp SHONGHOYA INTERNATIONAL GROUP INC.